Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin for Uremic Toxins in ESRD
NCT03452189Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Nov 2017
- Primary completion
- Aug 2018
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vancomycin in chronic kidney disease (CKD), sponsored by NYU Langone Health. Started Nov 2017; status: completed.
02
Drugs
vancomycin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT03452189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03452189.